Cat.#: ACPP-1311
| Despition | Leukemia Inhibitory Factor Human Recombinant |
| SIZE | 3 x 2 µg |
| Purity | > 98.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1664 | Human BLMH Protein (AC1664) | 5 µg | inquiry |
| ACPP-1423 | Human ALDH5A1 Protein (AC1423) | 2 µg | inquiry |
| ACPP-1032 | Recombinant Human PGRPS Protein (6×His Tag) (AC1032) | 50 µg | inquiry |
| ACPP-1131 | Recombinant Human/Murine/Rat BDNF Protein (AC1131) | 50 µg | inquiry |
| ACPP-1374 | Human Ephrin A4 Protein (AC1374) | 2 µg | inquiry |
| ACPP-1107 | Recombinant Human Syndecan-1 Protein (Fc Chimera 6xHis Tag) (AC1107) | 50 µg | inquiry |
| ACPP-1745 | Mouse Acrp30 Protein, His (AC1745) | 5 µg | inquiry |
| ACPP-1270 | Luteinizing Hormone Blocking Peptide (AC1270) | 250 µg | inquiry |
| ACPP-1218 | Dopamine D2 Receptor Blocking Peptide (AC1218) | 250 µg | inquiry |
| ACPP-1301 | SHISA9 Blocking Peptide (AC1301) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.